 Julie Haines
Concepts (380)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 16 | 2019 | 727 | 2.210 |
Why?
| | Erythrocytes | 12 | 2019 | 757 | 1.720 |
Why?
| | Cysteine | 8 | 2019 | 210 | 1.470 |
Why?
| | Nitrogen Oxides | 6 | 2014 | 54 | 1.370 |
Why?
| | Metabolome | 11 | 2019 | 384 | 1.300 |
Why?
| | Blood Preservation | 9 | 2019 | 354 | 1.290 |
Why?
| | Oxidation-Reduction | 13 | 2019 | 1087 | 0.730 |
Why?
| | Nitric Oxide Donors | 2 | 2012 | 20 | 0.710 |
Why?
| | Phosphines | 4 | 2014 | 18 | 0.700 |
Why?
| | Peroxiredoxins | 3 | 2018 | 26 | 0.700 |
Why?
| | Isotope Labeling | 3 | 2026 | 83 | 0.700 |
Why?
| | Mass Spectrometry | 8 | 2026 | 750 | 0.690 |
Why?
| | Sulfenic Acids | 3 | 2016 | 7 | 0.650 |
Why?
| | Hydrogen Peroxide | 3 | 2018 | 336 | 0.630 |
Why?
| | Proteins | 5 | 2016 | 1022 | 0.620 |
Why?
| | Eye Diseases, Hereditary | 1 | 2018 | 15 | 0.560 |
Why?
| | Erythrocyte Transfusion | 4 | 2019 | 231 | 0.550 |
Why?
| | Hydroxylamine | 1 | 2017 | 7 | 0.540 |
Why?
| | Glycolysis | 7 | 2019 | 340 | 0.530 |
Why?
| | Vitreous Body | 1 | 2018 | 117 | 0.530 |
Why?
| | Retinal Detachment | 1 | 2018 | 73 | 0.520 |
Why?
| | Diabetic Retinopathy | 1 | 2018 | 208 | 0.460 |
Why?
| | Hernias, Diaphragmatic, Congenital | 2 | 2019 | 219 | 0.460 |
Why?
| | Lipogenesis | 1 | 2026 | 62 | 0.450 |
Why?
| | Proteome | 2 | 2018 | 518 | 0.450 |
Why?
| | Leukemia, Myeloid, Acute | 3 | 2019 | 683 | 0.430 |
Why?
| | Chondrocytes | 2 | 2018 | 232 | 0.430 |
Why?
| | Neoplastic Stem Cells | 2 | 2019 | 412 | 0.430 |
Why?
| | Blood Proteins | 1 | 2017 | 249 | 0.430 |
Why?
| | Succinic Acid | 4 | 2018 | 42 | 0.430 |
Why?
| | Proteomics | 4 | 2018 | 1195 | 0.420 |
Why?
| | Neural Stem Cells | 1 | 2026 | 166 | 0.410 |
Why?
| | Plasma | 3 | 2019 | 225 | 0.400 |
Why?
| | Oxidative Phosphorylation | 3 | 2019 | 210 | 0.400 |
Why?
| | Extracellular Matrix | 1 | 2017 | 553 | 0.390 |
Why?
| | Triazenes | 1 | 2012 | 5 | 0.380 |
Why?
| | Cardiotonic Agents | 1 | 2012 | 95 | 0.360 |
Why?
| | Oxidative Stress | 5 | 2019 | 1339 | 0.360 |
Why?
| | Sulfhydryl Compounds | 2 | 2014 | 189 | 0.360 |
Why?
| | Sulfones | 1 | 2012 | 127 | 0.360 |
Why?
| | Lipids | 2 | 2019 | 710 | 0.340 |
Why?
| | Amino Acids | 3 | 2019 | 522 | 0.340 |
Why?
| | Stomach Ulcer | 1 | 2011 | 12 | 0.340 |
Why?
| | Indomethacin | 1 | 2011 | 76 | 0.330 |
Why?
| | Shock, Hemorrhagic | 3 | 2018 | 201 | 0.330 |
Why?
| | Macrophages | 3 | 2018 | 1511 | 0.330 |
Why?
| | Hydroxamic Acids | 1 | 2011 | 94 | 0.320 |
Why?
| | Prodrugs | 1 | 2011 | 52 | 0.320 |
Why?
| | Purines | 3 | 2018 | 187 | 0.310 |
Why?
| | Heart | 2 | 2019 | 636 | 0.310 |
Why?
| | Energy Metabolism | 5 | 2019 | 936 | 0.310 |
Why?
| | Mitochondria | 3 | 2017 | 984 | 0.310 |
Why?
| | Animals | 26 | 2026 | 38109 | 0.310 |
Why?
| | Lipid Metabolism | 3 | 2019 | 528 | 0.300 |
Why?
| | Electron Transport Complex II | 1 | 2019 | 28 | 0.300 |
Why?
| | Nitric Oxide | 2 | 2012 | 897 | 0.290 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2018 | 17 | 0.280 |
Why?
| | Antihypertensive Agents | 1 | 2012 | 511 | 0.280 |
Why?
| | Organogenesis | 1 | 2019 | 65 | 0.280 |
Why?
| | Gluconates | 1 | 2018 | 4 | 0.280 |
Why?
| | Antacids | 1 | 2018 | 16 | 0.280 |
Why?
| | Rejuvenation | 1 | 2018 | 18 | 0.270 |
Why?
| | Guanosine | 1 | 2018 | 40 | 0.270 |
Why?
| | Receptors, CCR2 | 1 | 2018 | 39 | 0.270 |
Why?
| | Lung | 3 | 2019 | 4109 | 0.270 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 338 | 0.270 |
Why?
| | Glycogen | 1 | 2017 | 54 | 0.260 |
Why?
| | Protein Processing, Post-Translational | 3 | 2018 | 477 | 0.260 |
Why?
| | Tracheal Stenosis | 1 | 2018 | 39 | 0.260 |
Why?
| | Interleukin-1beta | 2 | 2018 | 395 | 0.260 |
Why?
| | Cryopreservation | 2 | 2018 | 110 | 0.260 |
Why?
| | Glucose | 3 | 2026 | 1049 | 0.260 |
Why?
| | Fatty Acids | 2 | 2019 | 452 | 0.260 |
Why?
| | Airway Obstruction | 1 | 2019 | 162 | 0.250 |
Why?
| | Reactive Oxygen Species | 6 | 2019 | 621 | 0.250 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 103 | 0.250 |
Why?
| | Liver | 3 | 2018 | 1888 | 0.240 |
Why?
| | High-Throughput Screening Assays | 2 | 2019 | 175 | 0.240 |
Why?
| | Iron | 1 | 2018 | 359 | 0.230 |
Why?
| | Calpain | 1 | 2016 | 61 | 0.230 |
Why?
| | Troponin T | 1 | 2016 | 65 | 0.230 |
Why?
| | Humans | 39 | 2026 | 144957 | 0.230 |
Why?
| | Blood Pressure | 1 | 2012 | 1769 | 0.230 |
Why?
| | Cholestasis | 1 | 2018 | 219 | 0.220 |
Why?
| | src-Family Kinases | 1 | 2016 | 93 | 0.220 |
Why?
| | Wounds and Injuries | 3 | 2018 | 957 | 0.220 |
Why?
| | Temperature | 1 | 2018 | 679 | 0.220 |
Why?
| | Calcium Channels, L-Type | 1 | 2016 | 118 | 0.220 |
Why?
| | Cycloparaffins | 1 | 2014 | 2 | 0.210 |
Why?
| | Bridged Bicyclo Compounds | 1 | 2014 | 14 | 0.210 |
Why?
| | Fetus | 1 | 2019 | 803 | 0.210 |
Why?
| | NF-kappa B | 1 | 2018 | 662 | 0.210 |
Why?
| | Kynurenine | 1 | 2025 | 114 | 0.210 |
Why?
| | Carbon Isotopes | 3 | 2026 | 144 | 0.210 |
Why?
| | Peptide Fragments | 2 | 2016 | 699 | 0.210 |
Why?
| | Acute Lung Injury | 1 | 2017 | 303 | 0.210 |
Why?
| | Cells | 1 | 2014 | 25 | 0.200 |
Why?
| | Dithiothreitol | 1 | 2013 | 19 | 0.200 |
Why?
| | Dendritic Cells | 1 | 2017 | 499 | 0.200 |
Why?
| | Biomarkers | 6 | 2025 | 4275 | 0.200 |
Why?
| | Osteoarthritis | 1 | 2016 | 196 | 0.190 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 3 | 2014 | 179 | 0.190 |
Why?
| | Nucleic Acids | 1 | 2014 | 72 | 0.190 |
Why?
| | Fluorescent Dyes | 1 | 2014 | 330 | 0.190 |
Why?
| | Cartilage, Articular | 1 | 2016 | 343 | 0.180 |
Why?
| | Glutamine | 3 | 2026 | 109 | 0.170 |
Why?
| | Oxidants | 2 | 2019 | 103 | 0.170 |
Why?
| | DNA Damage | 1 | 2014 | 430 | 0.170 |
Why?
| | Biomedical Research | 1 | 2017 | 710 | 0.160 |
Why?
| | Disease Models, Animal | 7 | 2019 | 4569 | 0.160 |
Why?
| | Structure-Activity Relationship | 2 | 2012 | 570 | 0.160 |
Why?
| | S-Nitrosothiols | 1 | 2010 | 5 | 0.160 |
Why?
| | S-Nitrosoglutathione | 1 | 2010 | 8 | 0.160 |
Why?
| | Hemeproteins | 1 | 2010 | 8 | 0.160 |
Why?
| | Mice | 11 | 2019 | 18365 | 0.160 |
Why?
| | Molecular Structure | 3 | 2012 | 501 | 0.160 |
Why?
| | Models, Biological | 1 | 2017 | 1822 | 0.150 |
Why?
| | Kinetics | 3 | 2014 | 1629 | 0.150 |
Why?
| | Biocatalysis | 2 | 2014 | 69 | 0.150 |
Why?
| | Leukopoiesis | 1 | 2019 | 11 | 0.150 |
Why?
| | Myeloid Progenitor Cells | 1 | 2019 | 17 | 0.150 |
Why?
| | NADPH Oxidase 2 | 1 | 2019 | 35 | 0.150 |
Why?
| | Mice, Inbred C57BL | 6 | 2019 | 5997 | 0.150 |
Why?
| | Torpor | 1 | 2019 | 19 | 0.140 |
Why?
| | Cell Self Renewal | 1 | 2019 | 53 | 0.140 |
Why?
| | Heart Failure, Diastolic | 1 | 2019 | 24 | 0.140 |
Why?
| | Cardio-Renal Syndrome | 1 | 2019 | 18 | 0.140 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2014 | 143 | 0.140 |
Why?
| | Asparagine | 1 | 2018 | 35 | 0.140 |
Why?
| | Xanthine | 1 | 2018 | 7 | 0.140 |
Why?
| | Blood Banks | 1 | 2018 | 50 | 0.140 |
Why?
| | Aspartic Acid | 1 | 2018 | 88 | 0.140 |
Why?
| | Salmonella typhimurium | 1 | 2010 | 190 | 0.140 |
Why?
| | Arousal | 1 | 2019 | 157 | 0.140 |
Why?
| | Proteostasis | 1 | 2018 | 27 | 0.140 |
Why?
| | Erythrocytes, Abnormal | 1 | 2017 | 14 | 0.130 |
Why?
| | Methods | 1 | 2017 | 69 | 0.130 |
Why?
| | Hemoglobin A | 1 | 2017 | 21 | 0.130 |
Why?
| | Hemoglobin, Sickle | 1 | 2017 | 19 | 0.130 |
Why?
| | Hypoxanthine | 1 | 2017 | 11 | 0.130 |
Why?
| | Benzeneacetamides | 1 | 2017 | 8 | 0.130 |
Why?
| | Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2017 | 18 | 0.130 |
Why?
| | Glutaminase | 1 | 2017 | 11 | 0.130 |
Why?
| | Polypyrimidine Tract-Binding Protein | 1 | 2017 | 17 | 0.130 |
Why?
| | Pyruvate Kinase | 1 | 2017 | 28 | 0.130 |
Why?
| | Benzothiazoles | 1 | 2017 | 40 | 0.130 |
Why?
| | Sphingosine | 1 | 2017 | 45 | 0.130 |
Why?
| | Thiadiazoles | 1 | 2017 | 27 | 0.130 |
Why?
| | Sciuridae | 1 | 2019 | 152 | 0.130 |
Why?
| | Rabbits | 2 | 2019 | 648 | 0.130 |
Why?
| | fms-Like Tyrosine Kinase 3 | 1 | 2017 | 49 | 0.130 |
Why?
| | Solubility | 1 | 2017 | 242 | 0.130 |
Why?
| | Lysophospholipids | 1 | 2017 | 77 | 0.130 |
Why?
| | Chromatography, Affinity | 1 | 2017 | 85 | 0.130 |
Why?
| | Aging | 2 | 2018 | 1966 | 0.130 |
Why?
| | Phenylurea Compounds | 1 | 2017 | 112 | 0.120 |
Why?
| | Models, Molecular | 3 | 2018 | 1619 | 0.120 |
Why?
| | Leukemia | 1 | 2019 | 245 | 0.120 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 7 | 0.120 |
Why?
| | Fibronectins | 2 | 2018 | 136 | 0.120 |
Why?
| | Signal Transduction | 4 | 2018 | 5233 | 0.120 |
Why?
| | Time Factors | 5 | 2025 | 7183 | 0.120 |
Why?
| | Tandem Mass Spectrometry | 2 | 2016 | 577 | 0.120 |
Why?
| | Saline Solution, Hypertonic | 1 | 2016 | 42 | 0.120 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2017 | 331 | 0.120 |
Why?
| | Extracellular Matrix Proteins | 1 | 2017 | 159 | 0.120 |
Why?
| | Chromatography, High Pressure Liquid | 4 | 2018 | 598 | 0.120 |
Why?
| | Lactic Acid | 1 | 2018 | 302 | 0.120 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 112 | 0.120 |
Why?
| | Adenosine Triphosphate | 2 | 2019 | 498 | 0.120 |
Why?
| | Apolipoproteins | 1 | 2015 | 38 | 0.120 |
Why?
| | Esters | 2 | 2011 | 78 | 0.120 |
Why?
| | Reperfusion Injury | 1 | 2018 | 300 | 0.120 |
Why?
| | Stroke | 1 | 2025 | 1258 | 0.120 |
Why?
| | Ischemia | 1 | 2019 | 421 | 0.110 |
Why?
| | Muscle, Skeletal | 1 | 2016 | 1796 | 0.110 |
Why?
| | Chromatography, Liquid | 2 | 2019 | 454 | 0.110 |
Why?
| | Workflow | 1 | 2017 | 185 | 0.110 |
Why?
| | Inflammation Mediators | 2 | 2019 | 509 | 0.110 |
Why?
| | Lipoproteins, HDL | 1 | 2015 | 101 | 0.110 |
Why?
| | Cyclohexanones | 2 | 2016 | 9 | 0.110 |
Why?
| | Protein Stability | 2 | 2016 | 178 | 0.110 |
Why?
| | Healthy Volunteers | 2 | 2019 | 215 | 0.100 |
Why?
| | 2,3-Diphosphoglycerate | 2 | 2018 | 32 | 0.100 |
Why?
| | Peroxiredoxin III | 1 | 2013 | 1 | 0.100 |
Why?
| | Sulfinic Acids | 1 | 2013 | 6 | 0.100 |
Why?
| | Amino Acid Sequence | 2 | 2018 | 2157 | 0.100 |
Why?
| | Nitrogen Isotopes | 2 | 2017 | 72 | 0.100 |
Why?
| | Rats, Sprague-Dawley | 3 | 2018 | 2540 | 0.100 |
Why?
| | Anemia, Sickle Cell | 1 | 2017 | 312 | 0.100 |
Why?
| | Sulfonamides | 2 | 2018 | 581 | 0.100 |
Why?
| | Disulfides | 1 | 2013 | 96 | 0.100 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2013 | 396 | 0.090 |
Why?
| | Half-Life | 1 | 2012 | 151 | 0.090 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 531 | 0.090 |
Why?
| | Enzyme Activation | 1 | 2013 | 768 | 0.090 |
Why?
| | Female | 12 | 2025 | 78376 | 0.090 |
Why?
| | Swine | 3 | 2018 | 833 | 0.080 |
Why?
| | Carrageenan | 1 | 2011 | 8 | 0.080 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2017 | 631 | 0.080 |
Why?
| | MicroRNAs | 1 | 2017 | 701 | 0.080 |
Why?
| | Gastric Mucosa | 1 | 2011 | 52 | 0.080 |
Why?
| | Naproxen | 1 | 2011 | 21 | 0.080 |
Why?
| | Tryptophan | 2 | 2025 | 181 | 0.080 |
Why?
| | Stereoisomerism | 1 | 2011 | 105 | 0.080 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2011 | 81 | 0.080 |
Why?
| | Critical Illness | 1 | 2017 | 892 | 0.080 |
Why?
| | Acute Kidney Injury | 1 | 2019 | 866 | 0.080 |
Why?
| | Ibuprofen | 1 | 2011 | 84 | 0.080 |
Why?
| | Cells, Cultured | 3 | 2019 | 4155 | 0.080 |
Why?
| | Rats | 3 | 2018 | 5614 | 0.080 |
Why?
| | Male | 12 | 2025 | 72406 | 0.080 |
Why?
| | Edema | 1 | 2011 | 124 | 0.080 |
Why?
| | Epithelial Cells | 1 | 2016 | 1126 | 0.080 |
Why?
| | Hypoxia | 1 | 2017 | 1199 | 0.080 |
Why?
| | Cell Line | 2 | 2016 | 2882 | 0.070 |
Why?
| | Plasticizers | 1 | 2019 | 20 | 0.070 |
Why?
| | Succinate Dehydrogenase | 1 | 2019 | 67 | 0.070 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2931 | 0.070 |
Why?
| | Caspases, Initiator | 1 | 2018 | 17 | 0.070 |
Why?
| | Liver X Receptors | 1 | 2018 | 30 | 0.070 |
Why?
| | Vasoconstrictor Agents | 1 | 2019 | 144 | 0.070 |
Why?
| | Pulmonary Surfactants | 1 | 2019 | 102 | 0.070 |
Why?
| | Organ Size | 1 | 2019 | 463 | 0.070 |
Why?
| | Transplantation, Autologous | 1 | 2019 | 292 | 0.070 |
Why?
| | Glycogen Phosphorylase | 1 | 2017 | 2 | 0.070 |
Why?
| | Methionine | 1 | 2018 | 162 | 0.070 |
Why?
| | Solutions | 1 | 2018 | 167 | 0.070 |
Why?
| | Caspase 1 | 1 | 2018 | 148 | 0.070 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 192 | 0.070 |
Why?
| | Biological Transport | 1 | 2018 | 418 | 0.070 |
Why?
| | Azacitidine | 1 | 2018 | 157 | 0.060 |
Why?
| | Cell Respiration | 1 | 2017 | 107 | 0.060 |
Why?
| | Immune System | 1 | 2018 | 179 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 241 | 0.060 |
Why?
| | Glutathione | 1 | 2019 | 375 | 0.060 |
Why?
| | Receptors, Interleukin-1 | 1 | 2018 | 214 | 0.060 |
Why?
| | Caspases | 1 | 2018 | 232 | 0.060 |
Why?
| | Parenteral Nutrition | 1 | 2018 | 105 | 0.060 |
Why?
| | Trachea | 1 | 2019 | 261 | 0.060 |
Why?
| | Mutation | 2 | 2013 | 4099 | 0.060 |
Why?
| | Hemoglobins | 2 | 2018 | 384 | 0.060 |
Why?
| | Hepatocytes | 1 | 2018 | 224 | 0.060 |
Why?
| | Lipoproteins | 1 | 2018 | 169 | 0.060 |
Why?
| | In Vitro Techniques | 1 | 2018 | 1048 | 0.060 |
Why?
| | Immunologic Factors | 1 | 2019 | 255 | 0.060 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2018 | 280 | 0.060 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 210 | 0.060 |
Why?
| | Muscle Fibers, Fast-Twitch | 1 | 2016 | 17 | 0.060 |
Why?
| | Matrix Metalloproteinase 13 | 1 | 2016 | 25 | 0.060 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 3550 | 0.060 |
Why?
| | Muscle Fibers, Slow-Twitch | 1 | 2016 | 23 | 0.060 |
Why?
| | History, Ancient | 1 | 2016 | 56 | 0.060 |
Why?
| | Hypertension, Pulmonary | 1 | 2017 | 1980 | 0.060 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2016 | 87 | 0.060 |
Why?
| | Analysis of Variance | 1 | 2018 | 1311 | 0.060 |
Why?
| | Cell Proliferation | 2 | 2017 | 2499 | 0.060 |
Why?
| | Cell Lineage | 1 | 2017 | 376 | 0.060 |
Why?
| | Pregnancy | 2 | 2019 | 7191 | 0.060 |
Why?
| | Immunoblotting | 1 | 2016 | 300 | 0.060 |
Why?
| | Vasodilation | 1 | 2018 | 523 | 0.060 |
Why?
| | Muscle Fatigue | 1 | 2016 | 97 | 0.050 |
Why?
| | Cytokines | 2 | 2017 | 2065 | 0.050 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 336 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2017 | 442 | 0.050 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1540 | 0.050 |
Why?
| | Inflammation | 1 | 2016 | 2880 | 0.050 |
Why?
| | Microscopy, Confocal | 1 | 2016 | 321 | 0.050 |
Why?
| | Peptide Mapping | 1 | 2014 | 63 | 0.050 |
Why?
| | Molecular Probes | 1 | 2014 | 33 | 0.050 |
Why?
| | Homeostasis | 1 | 2018 | 640 | 0.050 |
Why?
| | Cell Survival | 1 | 2017 | 1098 | 0.050 |
Why?
| | Iodoacetamide | 1 | 2013 | 5 | 0.050 |
Why?
| | Isometric Contraction | 1 | 2016 | 188 | 0.050 |
Why?
| | Ethylmaleimide | 1 | 2013 | 18 | 0.050 |
Why?
| | Methyl Methanesulfonate | 1 | 2013 | 7 | 0.050 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 863 | 0.050 |
Why?
| | Radiation, Ionizing | 1 | 2014 | 87 | 0.050 |
Why?
| | Oxygen | 1 | 2018 | 995 | 0.050 |
Why?
| | HeLa Cells | 1 | 2014 | 650 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2025 | 8279 | 0.050 |
Why?
| | Cell Nucleus | 1 | 2016 | 619 | 0.050 |
Why?
| | Myocardium | 2 | 2019 | 939 | 0.050 |
Why?
| | Biomechanical Phenomena | 1 | 2016 | 842 | 0.050 |
Why?
| | Hypoglycemia | 1 | 2017 | 477 | 0.050 |
Why?
| | Mice, Transgenic | 2 | 2017 | 2185 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2013 | 180 | 0.050 |
Why?
| | Up-Regulation | 1 | 2025 | 852 | 0.040 |
Why?
| | Adult | 5 | 2019 | 40506 | 0.040 |
Why?
| | Pneumonia | 1 | 2017 | 631 | 0.040 |
Why?
| | Colorado | 2 | 2025 | 4564 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 2016 | 1258 | 0.040 |
Why?
| | Microbiota | 1 | 2018 | 781 | 0.040 |
Why?
| | Nitrosation | 1 | 2010 | 8 | 0.040 |
Why?
| | Horseradish Peroxidase | 1 | 2010 | 26 | 0.040 |
Why?
| | Myoglobin | 1 | 2010 | 12 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1786 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2032 | 0.040 |
Why?
| | Guanylate Cyclase | 1 | 2010 | 39 | 0.040 |
Why?
| | Electron Transport Complex IV | 1 | 2010 | 62 | 0.040 |
Why?
| | Catalase | 1 | 2010 | 130 | 0.040 |
Why?
| | Aza Compounds | 1 | 2009 | 13 | 0.040 |
Why?
| | Protein Binding | 1 | 2016 | 2276 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2017 | 2050 | 0.040 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3415 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2016 | 1496 | 0.040 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2010 | 162 | 0.040 |
Why?
| | Cryoprotective Agents | 1 | 2018 | 11 | 0.040 |
Why?
| | Osmotic Fragility | 1 | 2018 | 12 | 0.040 |
Why?
| | Erythrocyte Indices | 1 | 2018 | 33 | 0.040 |
Why?
| | Erythrocyte Deformability | 1 | 2018 | 23 | 0.040 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2609 | 0.040 |
Why?
| | Glycerol | 1 | 2018 | 90 | 0.040 |
Why?
| | Sulfur | 1 | 2019 | 64 | 0.040 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2018 | 199 | 0.030 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 194 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2019 | 202 | 0.030 |
Why?
| | Hibernation | 1 | 2019 | 80 | 0.030 |
Why?
| | Deamination | 1 | 2017 | 6 | 0.030 |
Why?
| | Methylation | 1 | 2018 | 242 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2016 | 3608 | 0.030 |
Why?
| | Water | 1 | 2011 | 469 | 0.030 |
Why?
| | Antagomirs | 1 | 2017 | 12 | 0.030 |
Why?
| | Naphthoquinones | 1 | 2017 | 19 | 0.030 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2018 | 131 | 0.030 |
Why?
| | Liquid-Liquid Extraction | 1 | 2017 | 14 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2018 | 224 | 0.030 |
Why?
| | Crush Injuries | 1 | 2017 | 12 | 0.030 |
Why?
| | Pentose Phosphate Pathway | 1 | 2017 | 55 | 0.030 |
Why?
| | Freezing | 1 | 2017 | 86 | 0.030 |
Why?
| | Lactates | 1 | 2017 | 83 | 0.030 |
Why?
| | Swine, Miniature | 1 | 2017 | 89 | 0.030 |
Why?
| | Reference Standards | 1 | 2017 | 178 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2018 | 455 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2018 | 2197 | 0.030 |
Why?
| | Primates | 1 | 2018 | 132 | 0.030 |
Why?
| | Mice, Nude | 1 | 2018 | 688 | 0.030 |
Why?
| | Chemical Fractionation | 1 | 2016 | 28 | 0.030 |
Why?
| | Femoral Fractures | 1 | 2017 | 82 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2018 | 493 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 1 | 2017 | 187 | 0.030 |
Why?
| | Protein Folding | 1 | 2018 | 279 | 0.030 |
Why?
| | Risk Factors | 2 | 2025 | 10792 | 0.030 |
Why?
| | Bronchioles | 1 | 2016 | 29 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2019 | 744 | 0.030 |
Why?
| | Databases, Protein | 1 | 2016 | 90 | 0.030 |
Why?
| | Middle Aged | 3 | 2025 | 35928 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2018 | 6434 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 99 | 0.030 |
Why?
| | Apolipoprotein L1 | 1 | 2015 | 14 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2017 | 402 | 0.030 |
Why?
| | Proteolysis | 1 | 2016 | 173 | 0.030 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2017 | 220 | 0.030 |
Why?
| | Hemolysis | 1 | 2017 | 243 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 151 | 0.030 |
Why?
| | Echocardiography | 1 | 2019 | 652 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 476 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2017 | 610 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2017 | 251 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3869 | 0.030 |
Why?
| | Alternative Splicing | 1 | 2017 | 249 | 0.030 |
Why?
| | Risk Assessment | 1 | 2025 | 3676 | 0.030 |
Why?
| | Aged | 2 | 2025 | 25947 | 0.030 |
Why?
| | Cattle | 1 | 2017 | 1000 | 0.030 |
Why?
| | Trauma Centers | 1 | 2017 | 462 | 0.030 |
Why?
| | Intestines | 1 | 2017 | 358 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2017 | 930 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2015 | 373 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 2118 | 0.020 |
Why?
| | Fibroblasts | 1 | 2017 | 1034 | 0.020 |
Why?
| | Kidney Diseases | 1 | 2015 | 427 | 0.020 |
Why?
| | Kidney | 1 | 2019 | 1496 | 0.020 |
Why?
| | Endothelium, Vascular | 1 | 2017 | 965 | 0.020 |
Why?
| | Peptides | 1 | 2016 | 998 | 0.020 |
Why?
| | Genetic Variation | 1 | 2015 | 984 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 3164 | 0.020 |
Why?
| | Prognosis | 1 | 2017 | 4293 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2015 | 2365 | 0.020 |
Why?
| | Brain | 1 | 2016 | 2941 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2015 | 2171 | 0.010 |
Why?
|
|
Haines's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|